What is Bambusa Therapeutics worth?
$555.0Mlast known valuation
Bambusa Therapeutics last raised $40.0M in its Early Stage VC (Series A2) (Oct 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Bambusa Therapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Early Stage VC (Series A2) | $40.0M | ▮ | ▮ |
| Feb 2025 | Early Stage VC (Series A) | $88.9M | ▮ | ▮ |
| Jun 2024 | Early Stage VC | $9.0M | ▮ | ▮ |
| Jun 2024 | Early Stage VC | $5.1M | ▮ | ▮ |
How Bambusa Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Bambusa Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Bambusa Therapeutics worth?
- Bambusa Therapeutics's last known valuation is $555.0M.
- How much has Bambusa Therapeutics raised?
- Bambusa Therapeutics has raised $143.0M in total funding across 4 recorded rounds.
- When did Bambusa Therapeutics last raise?
- Bambusa Therapeutics last raised in Oct 2025 (Early Stage VC (Series A2)), raising $40.0M.